0001765581-20-000111.txt : 20201109 0001765581-20-000111.hdr.sgml : 20201109 20201109165345 ACCESSION NUMBER: 0001765581-20-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201105 FILED AS OF DATE: 20201109 DATE AS OF CHANGE: 20201109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Keefe Kenneth W CENTRAL INDEX KEY: 0001397661 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33500 FILM NUMBER: 201298441 MAIL ADDRESS: STREET 1: C/O BEECKEN PETTY O'KEEFE & COMPANY STREET 2: 131 S. DEARBORN STREET, SUITE 2800 CITY: CHICAGO STATE: IL ZIP: 60603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc CENTRAL INDEX KEY: 0001232524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981032470 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE STREET 2: WATERLOO ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 353-1-634-7800 MAIL ADDRESS: STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE STREET 2: WATERLOO ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030513 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-11-05 0 0001232524 Jazz Pharmaceuticals plc JAZZ 0001397661 O'Keefe Kenneth W 5TH FL, WATERLOO EXCHANGE WATERLOO RD DUBLIN 4 L2 IRELAND 1 0 0 0 Ordinary Shares 2020-11-05 4 S 0 2001 152.5711 D 27666 D Ordinary Shares 2020-11-05 4 S 0 2740 153.7428 D 24926 D Ordinary Shares 2020-11-05 4 S 0 1746 155.1359 D 23180 D Ordinary Shares 2020-11-05 4 S 0 4513 156.4377 D 18667 D Ordinary Shares 4445 I by Trust This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $152.319 to $152.83 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $153.355 to $154.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $154.91 to $155.73 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $156.00 to $156.99 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary. By: /s/Doris Choi, as attorney in fact For: Kenneth W O'Keefe 2020-11-08